17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Cryopreservation and its clinical applications

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Cryopreservation is a process that preserves organelles, cells, tissues, or any other biological constructs by cooling the samples to very low temperatures. The responses of living cells to ice formation are of theoretical interest and practical relevance. Stem cells and other viable tissues, which have great potential for use in basic research as well as for many medical applications, cannot be stored with simple cooling or freezing for a long time because ice crystal formation, osmotic shock, and membrane damage during freezing and thawing will cause cell death. The successful cryopreservation of cells and tissues has been gradually increasing in recent years, with the use of cryoprotective agents and temperature control equipment. Continuous understanding of the physical and chemical properties that occur in the freezing and thawing cycle will be necessary for the successful cryopreservation of cells or tissues and their clinical applications. In this review, we briefly address representative cryopreservation processes, such as slow freezing and vitrification, and the available cryoprotective agents. In addition, some adverse effects of cryopreservation are mentioned.

          Related collections

          Most cited references48

          • Record: found
          • Abstract: not found
          • Article: not found

          Revival of spermatozoa after vitrification and dehydration at low temperatures.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Protectants used in the cryopreservation of microorganisms.

            The cryoprotective additives (CPAs) used in the frozen storage of microorganisms (viruses, bacteria, fungi, algae, and protozoa) include a variety of simple and more complex chemical compounds, but only a few of them have been used widely and with satisfactory results: these include dimethylsulfoxide (Me2SO), glycerol, blood serum or serum albumin, skimmed milk, peptone, yeast extract, saccharose, glucose, methanol, polyvinylpyrrolidone (PVP), sorbitol, and malt extract. Pairwise comparisons of the cryoprotective activity of the more common CPAs used in cryomicrobiology, based on published experimental reports, indicate that the most successful CPAs have been Me2SO, methanol, ethylene glycol, propylene glycol, and serum or serum albumin, while glycerol, polyethylene glycol, PVP, and sucrose are less successful, and other sugars, dextran, hydroxyethyl starch, sorbitol, and milk are the least effective. However, diols (as well as some other CPAs) are toxic for many microbes. Me2SO might be regarded as the most universally useful CPA, although certain other CPAs can sometimes yield better recoveries with particular organisms. The best CPA, or combination of CPAs, and the optimum concentration for a particular cryosensitive microorganism has to be determined empirically. This review aims to provide a summary of the main experimental findings with a wide range of additives and organisms. A brief discussion of mechanisms of CPA action is also included.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Prevention of freezing damage to living cells by dimethyl sulphoxide.

                Bookmark

                Author and article information

                Contributors
                Journal
                Integr Med Res
                Integr Med Res
                Integrative Medicine Research
                Elsevier
                2213-4220
                2213-4239
                10 January 2017
                March 2017
                10 January 2017
                : 6
                : 1
                : 12-18
                Affiliations
                [a ]College of Medicine, Inje University, Busan, Korea
                [b ]Cardiovascular and Metabolic Disease Center, College of Medicine, Inje University, Busan, Korea
                Author notes
                [* ] Corresponding authors. National Research Laboratory for Mitochondrial Signaling, Department of Physiology, Department of Health Sciences and Technology, BK21 plus Project Team, Cardiovascular and Metabolic Disease Center, College of Medicine, Inje University, Bokji-ro 75, Busanjin-gu, Busan 47392, Republic of Korea (J. Han); Cardiovascular and Metabolic Disease Center, Department of Integrated Biomedical Science, College of Medicine, Inje University, Bokji-ro 75, Busanjin-gu, Busan 47392, Republic of Korea (S.R. Lee). lsr1113@ 123456inje.ac.kr phyhanj@ 123456inje.ac.kr
                [1]

                These authors contributed equally to this work.

                Article
                S2213-4220(16)30155-X
                10.1016/j.imr.2016.12.001
                5395684
                28462139
                f028d95d-480e-4dc9-8144-4703f6a85ea6
                © 2017 Korea Institute of Oriental Medicine. Published by Elsevier.

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                : 10 November 2016
                : 28 November 2016
                : 8 December 2016
                Categories
                Review Article

                cryoinjury,cryopreservation,cryoprotective agent,slow freezing,vitrification

                Comments

                Comment on this article